Applied Therapeutics (APLT) News Today → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free APLT Stock Alerts $4.67 +0.17 (+3.78%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 8:02 AM | insidertrades.comInsider Selling: Applied Therapeutics, Inc. (NASDAQ:APLT) Major Shareholder Sells 150,000 Shares of StockJune 6 at 7:41 PM | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Major Shareholder Sells $631,500.00 in StockApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) major shareholder Real Estate Equitie Alexandria sold 150,000 shares of the stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $4.21, for a total transaction of $631,500.00. Following the completion of the sale, the insider now directly owns 6,005,077 shares in the company, valued at $25,281,374.17. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.June 3, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Up 10%Applied Therapeutics (NASDAQ:APLT) Trading Up 10%May 28, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Stock Price Up 7.6%Applied Therapeutics (NASDAQ:APLT) Stock Price Up 7.6%May 28, 2024 | seekingalpha.comApplied Therapeutics: Navigating Challenges In ARI Development For Rare DiseasesMay 28, 2024 | marketbeat.comFranklin Resources Inc. Sells 929,100 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)Franklin Resources Inc. decreased its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 11.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,017,912 shares of the company'sMay 27, 2024 | marketbeat.comAIGH Capital Management LLC Purchases 865,689 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)AIGH Capital Management LLC grew its stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 109.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,659,039 shares of the company'sMay 20, 2024 | marketbeat.comWorth Venture Partners LLC Has $1.38 Million Stake in Applied Therapeutics, Inc. (NASDAQ:APLT)Worth Venture Partners LLC raised its stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 112.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 412,981 shares of the company's stock after purchasing an additional 219,May 14, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Gap Down to $4.43Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $4.43May 10, 2024 | finance.yahoo.comApplied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...May 9, 2024 | investorplace.comAPLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024May 9, 2024 | msn.comApplied Therapeutics GAAP EPS of -$0.67 misses by $0.51May 9, 2024 | globenewswire.comApplied Therapeutics Reports First Quarter 2024 Financial ResultsMay 7, 2024 | finance.yahoo.comApplied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceApril 17, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Stock Price Down 3.3%Applied Therapeutics (NASDAQ:APLT) Stock Price Down 3.3%April 16, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Trading 4.2% Higher Applied Therapeutics (NASDAQ:APLT) Shares Up 4.2%April 15, 2024 | globenewswire.comApplied Therapeutics Appoints Dale Hooks as Chief Commercial OfficerApril 14, 2024 | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Applied Therapeutics (APLT)April 13, 2024 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Sees Significant Increase in Short InterestApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 4,980,000 shares, an increase of 31.4% from the March 15th total of 3,790,000 shares. Based on an average trading volume of 2,070,000 shares, the days-to-cover ratio is presently 2.4 days.April 9, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Down 3.7% Applied Therapeutics (NASDAQ:APLT) Trading Down 3.7%April 6, 2024 | investing.comApplied Therapeutics reveals Phase 3 data on heart drugApril 4, 2024 | finance.yahoo.comApplied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024April 3, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Trading Down 2.8%Applied Therapeutics (NASDAQ:APLT) Trading Down 2.8%April 3, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Applied Therapeutics (APLT) and Vincerx Pharma Inc (VINC)April 1, 2024 | benzinga.comFDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare DiseaseApril 1, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.80Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.80April 1, 2024 | benzinga.comWhy Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving PremarketMarch 29, 2024 | markets.businessinsider.comApplied Therapeutics Says FDA Extends Review Period Of NDA For GovorestatMarch 28, 2024 | finance.yahoo.comUPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drugMarch 28, 2024 | reuters.comUS FDA extends review of Applied Therapeutics' genetic disease drugMarch 28, 2024 | globenewswire.comApplied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic GalactosemiaMarch 26, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Now Covered by Royal Bank of CanadaRoyal Bank of Canada initiated coverage on shares of Applied Therapeutics in a report on Tuesday. They set an "outperform" rating and a $12.00 price target on the stock.March 25, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75March 20, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Up 4.6%Applied Therapeutics (NASDAQ:APLT) Trading Up 4.6%March 20, 2024 | investing.comApplied therapeutics CCO sells shares worth over $263kMarch 20, 2024 | investing.comApplied therapeutics CFO sells shares worth over $150kMarch 19, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Gap Down Following Insider SellingApplied Therapeutics (NASDAQ:APLT) Shares Gap Down Following Insider SellingMarch 19, 2024 | insidertrades.comInsider Selling: Applied Therapeutics, Inc. (NASDAQ:APLT) CFO Sells 28,727 Shares of StockMarch 19, 2024 | insidertrades.comApplied Therapeutics, Inc. (NASDAQ:APLT) CEO Shoshana Shendelman Sells 318,573 SharesMarch 18, 2024 | marketbeat.comLeslie D. Funtleyder Sells 28,727 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) StockApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) CFO Leslie D. Funtleyder sold 28,727 shares of the firm's stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $5.39, for a total value of $154,838.53. Following the completion of the sale, the chief financial officer now owns 308,421 shares in the company, valued at $1,662,389.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.March 18, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Price Target Increased to $13.00 by Analysts at UBS GroupUBS Group lifted their price target on Applied Therapeutics from $12.00 to $13.00 and gave the company a "buy" rating in a research report on Friday.March 11, 2024 | marketbeat.comLeerink Partnrs Research Analysts Increase Earnings Estimates for Applied Therapeutics, Inc. (NASDAQ:APLT)Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) - Research analysts at Leerink Partnrs raised their Q1 2024 EPS estimates for Applied Therapeutics in a research note issued on Wednesday, March 6th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will post earnings perMarch 10, 2024 | marketbeat.comSchonfeld Strategic Advisors LLC Makes New $1.14 Million Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)Schonfeld Strategic Advisors LLC acquired a new position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 457,400 shares of the company's stock, vMarch 8, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Trading 6.5% Higher Applied Therapeutics (NASDAQ:APLT) Trading Up 6.5%March 8, 2024 | finance.yahoo.comApplied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical ProgressMarch 6, 2024 | marketbeat.comUBS Group Increases Applied Therapeutics (NASDAQ:APLT) Price Target to $12.00UBS Group lifted their price target on Applied Therapeutics from $4.00 to $12.00 and gave the company a "buy" rating in a research note on Wednesday.March 6, 2024 | marketbeat.comWorth Venture Partners LLC Makes New $483,000 Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)Worth Venture Partners LLC acquired a new position in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 193,973 shares of the company's stocMarch 6, 2024 | globenewswire.comApplied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial ResultsMarch 5, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Trading Down 5.7%Applied Therapeutics (NASDAQ:APLT) Trading Down 5.7%March 3, 2024 | marketbeat.comArmistice Capital LLC Takes Position in Applied Therapeutics, Inc. (NASDAQ:APLT)Armistice Capital LLC bought a new stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,400,000 shares of the company's stock, valued at approximately $8,4 Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd). Get all the details here. APLT Media Mentions By Week APLT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLT News Sentiment▼0.540.72▲Average Medical News Sentiment APLT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLT Articles This Week▼42▲APLT Articles Average Week Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Avid Bioservices News Puma Biotechnology News Rigel Pharmaceuticals News G1 Therapeutics News Zai Lab News Catalyst Pharmaceuticals News Galapagos News Keros Therapeutics News Evotec News Protagonist Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLT) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored